Jump to content

Opioid crisis: Johnson & Johnson hit by landmark ruling


Recommended Posts

https://www.bbc.com/news/business-49452373

 

Drugmaker Johnson & Johnson must pay $572m (£469m) for its part in fuelling the opioid addiction crisis in Oklahoma, a US judge has ruled

The company said immediately after the judgement that it would appeal.

The case was the first to go to trial out of thousands of lawsuits filed against opioid makers and distributors.

Earlier this year, Oklahoma settled with OxyContin maker Purdue Pharma for $270m and Teva Pharmaceutical for $85m, leaving J&J as the lone defendant.

Judge Thad Balkman said prosecutors had demonstrated that J&J contributed to a "public nuisance" in its deceptive promotion of highly addictive prescription painkillers.

"Those actions compromised the health and safety of thousands of Oklahomans. The opioid crisis is an imminent danger and menace to Oklahomans," he said in his ruling.

The payment would be used for the care and treatment of opioid addicts, he said.

Deaths

The outcome of the case is being closely watched by plaintiffs in about 2,000 opioid lawsuits due to go to trial in Ohio in October unless the parties can reach a settlement.

Opioids were involved in almost 400,000 overdose deaths from 1999 to 2017, according to the US Centers for Disease Control and Prevention. Since 2000, some 6,000 people in Oklahoma have died from opioid overdoses, according to the state's lawyers.

 
 

During Oklahoma's seven-week non-jury trial, lawyers for the state argued that J&J carried out a years-long marketing campaign that minimised the addictive painkillers' risks and promoted their benefits.

The state's lawyers had called J&J an opioid "kingpin" and argued that its marketing efforts created a public nuisance as doctors over-prescribed the drugs, leading to a surge in overdose deaths in Oklahoma.

J&J vigorously denied wrongdoing, arguing that its marketing claims had scientific support and that its painkillers, Duragesic and Nucynta, made up a tiny fraction of opioids prescribed in Oklahoma.

  Image copyright Getty Images Image caption America is the biggest consumer of opioids, followed by Canada and Germany.

The state's case rested on a "radical" interpretation of the state's public nuisance law, J&J said.

 

The company said in a statement that since 2008, its painkillers accounted for less than 1% of the US market, including generics.

 

"The decision in this case is flawed. The State failed to present evidence that the company's products or actions caused a public nuisance in Oklahoma.

 

"This judgment is a misapplication of public nuisance law that has already been rejected by judges in other states," it added.

 

The Oklahoma case was brought by the state's Attorney General Mike Hunter. "Johnson & Johnson will finally be held accountable for thousands of deaths and addictions caused by their actions," he said after the ruling.

 Cymbalta, Zyprexa, Seroquil, Rispiridone, Valium, Zoloft, Clonazepam,. + 1 other Benzo. Total 11 yrs.

·           April 9th 2018 Hospital. 50mg Zoloft > 0 discontinued. 6mg Clonazepam > 2.5mg over 8 weeks stay.

           October 25th 2019: Hospital:  Clonazepam Bridged 1mg > to 20mg Diazepam.

           

           Anafranil: 90mg. 85mg 1/04/21

      
  Diazepam (V): 25th October 2019, 20mg. 22 Dec 2019 19mg. 4 April 20: 18mg,  30 September: 17.5mg , 13 November 20: 17mg 01 January 2021: 16mg, 13/08: 15mg

Link to post
Share on other sites

I posted this as there was a show on Australia's public channel: ABC 7:30 report, about Benzodiazepines. During the ABC report on 7:30 program it stating that Benzo's are a bigger killer than the Opoids scandal hitting the U.S, affecting over 1.3 million Aussie's.

 

Thinking Opoids are just the top of the tree of Class A drugs that people have difficulty in coming off.

 Cymbalta, Zyprexa, Seroquil, Rispiridone, Valium, Zoloft, Clonazepam,. + 1 other Benzo. Total 11 yrs.

·           April 9th 2018 Hospital. 50mg Zoloft > 0 discontinued. 6mg Clonazepam > 2.5mg over 8 weeks stay.

           October 25th 2019: Hospital:  Clonazepam Bridged 1mg > to 20mg Diazepam.

           

           Anafranil: 90mg. 85mg 1/04/21

      
  Diazepam (V): 25th October 2019, 20mg. 22 Dec 2019 19mg. 4 April 20: 18mg,  30 September: 17.5mg , 13 November 20: 17mg 01 January 2021: 16mg, 13/08: 15mg

Link to post
Share on other sites

Here is the program for those who can access it online. 

 

https://www.abc.net.au/7.30/a-warning-for-1.5-million-australians-on/11406982

Current Dose

0.5mcg Clonidine and 1.25 Diazepam PRN for treatment of iatrogenic hypertension. 

2010 .Prescribed Pristiq 100 mg in July by GP

2010 .Reduced to 50mg by splitting and weighing. Held at 50mg

2014. Reduced from 50-35 .Held at 35mg. 

2017. Taper from 35mg commenced using compounded Desvenlafaxine

2018. 23/06 13.5mg. 21/07  12.5mg. 25/08 11.5mg. 09/2018 10mg. 14/11 11mg (updose) 21/11 -12mg (updose)

2019. Still holding at 12mg and stuck. 

2020. January 2019 Prozac Bridge-- Prozac 2.5 to 10mg and

Pristiq 23rd Jan 6mg/ 27th Jan 5mg/ 28th Jan 3mg/ 30 Jan 0

Prozac 6th Feb 9.5mg. Vitamin D3 5000iu with K2

Magnesium Glycinate with Glycine and Passionflower  600mg 

Link to post
Share on other sites

Thanks Andie, I think the short doco in the link is worth watching. (10 mins)

 

I can't say any amount of money or compensation will fix anything for me. But atleast they mention a Royal Comission into Benzo's for 2020, which is the start of some justice in preventing any further wrongdoing to others.

 Cymbalta, Zyprexa, Seroquil, Rispiridone, Valium, Zoloft, Clonazepam,. + 1 other Benzo. Total 11 yrs.

·           April 9th 2018 Hospital. 50mg Zoloft > 0 discontinued. 6mg Clonazepam > 2.5mg over 8 weeks stay.

           October 25th 2019: Hospital:  Clonazepam Bridged 1mg > to 20mg Diazepam.

           

           Anafranil: 90mg. 85mg 1/04/21

      
  Diazepam (V): 25th October 2019, 20mg. 22 Dec 2019 19mg. 4 April 20: 18mg,  30 September: 17.5mg , 13 November 20: 17mg 01 January 2021: 16mg, 13/08: 15mg

Link to post
Share on other sites
×
×
  • Create New...

Important Information

Terms of Use Privacy Policy